← All stocks

Biohaven Ltd.

BHVN Net buying

CIK 0001935979 #2019 in the set updated 17 Sep 2026

Bought (120 mo)

$145.34M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$459.66K

$0.00 on a plan · $459.66K straight out of an exercise

Sold at will

$0.00

0 of 1 sales

Net

+$144.88M

+$145.34M against sales at will

By person

13 insiders · 100 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

CHILDS JOHN W

Director

$95.36M (20)

—

+$95.36M

11,345,155

7.51%

$96.61M

+787.6%

Coric Vlad

Chief Executive Officer

$37.49M (19)

—

+$37.49M

2,544,514

1.68%

$21.67M

—

Bailey Gregory

Director

$9.24M (7)

—

+$9.24M

2,020,071

1.34%

$17.20M

—

Buten Matthew

Chief Financial Officer

$2.00M (2)

—

+$2.00M

195,652

0.1295%

$1.67M

+6,584%

Car Bruce

Chief Scientific Officer

$1.01M (1)

—

+$1.01M

37,715

0.0250%

$321.18K

+1,189%

Antonijevic Irina

Director

—

$459.66K (1) scheduled

−$459.66K

2,535

0.0017%

$21.59K

—

Clark George C.

VP, Chief Accounting Officer

$144.77K (1)

—

+$144.77K

86,978

0.0576%

$740.70K

+29.4%

GREGORY JULIA P

Director

$99.99K (1)

—

+$99.99K

25,665

0.0170%

$218.56K

—

Gentile Kimberly

SVP, Clinical Operations

—

99,557

0.0659%

$847.82K

—

Mehta Kishan

Director

—

22,662

0.0150%

$192.99K

—

HUGIN ROBERT J

Director

—

19,486

0.0129%

$165.94K

—

Heffernan Michael Thomas

Director

—

19,370

0.0128%

$164.95K

—

Biohaven Pharmaceutical Holding Co Ltd. entity

10% owner

—

0.0000%

$0.00

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 106

Amendments (4/A) skipped 8

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 1

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 76,404,592

History held since 5 Oct 2022